Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-28T04:26:03.199Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessment of Low Dosage Haloperidol in Anxiety States

Published online by Cambridge University Press:  29 January 2018

Rowland Rogerson  and
John K. Butler
Rowland Rogerson
Affiliation:
The Surgery, Mizzen Road, Beverley High Road, Hull, Yorks
John K. Butler
Affiliation:
G. D. Searle and Co. Ltd., High Wycombe, Bucks., and Churchill Hospital, Oxford
Get access Rights & Permissions [Opens in a new window]

Extract

The trial was a double-blind cross-over study in which patients presenting in general practice with anxiety received haloperidol (Serenace) 0·5 mg. twice daily for two weeks and a placebo of identical appearance for two weeks in random order. Forty-three patients entered the trial. Of these, six failed to attend for follow-up and one proved impossible to assess. A further eight completed the first two-week period of assessment only (5 active drug, 3 placebo) but are included in the analysis. There were equal numbers of men and women, aged 24 to 71 years.

Type
Abstract
Information
The British Journal of Psychiatry , Volume 119 , Issue 549 , August 1971 , pp. 169 - 170
Copyright
Copyright © The Royal College of Psychiatrists, 1971 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hamilton, M. (1959). British Journal of Medical Psychology, 32, 50–5.CrossRefGoogle Scholar
Hargreaves, G. R., Hamilton, M., and Roberts, J. M. (1958). Journal of Menial Science, 104, 1056–61.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.